Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Organicell Regenerative Medicine, Inc. Organicell Announces Matt Sinnreich as CEO July 26, 2022 From Organicell Regenerative Medicine, Inc. Via AccessWire Topics Derivatives Exposures Derivatives Tickers OCEL Organicell Regenerative Medicine, Inc. Secures $4 Million in Funding for Clinical Trials and Agrees To Restructure Management July 20, 2022 From Organicell Regenerative Medicine, Inc. Via AccessWire Exposures COVID-19 Product Safety Tickers OCEL Organicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activities December 29, 2021 From Organicell Regenerative Medicine, Inc. Via AccessWire Tickers OCEL Organicell Announces Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using ZofinTM June 15, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell Launches Autologous Blood Derived Platform PPX™ – Patient Pure X™ June 09, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell To Present Results Of Zofin™ Clinical Studies At The International Society Of Cell And Gene Therapy Annual Meeting May 25, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell Signs an Exclusive Distribution Agreement with Apex Services in Pakistan May 19, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell Receives Approval in Pakistan for the Use of Zofin™ for Compassionate Grounds for COVID-19 May 11, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell Begins Up-Listing Process On NASDAQ Exchange May 04, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion April 28, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19 Patients with Zofin™ April 22, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Osteoarthritis April 21, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential April 14, 2021 From Organicell Regenerative Medicine, Inc. Via Business Wire Tickers OTC Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.